Brought to you by 
IPO nets $417mm for 10x Genomics
23 Jan 2020
Executive Summary
Life science technology company 10x Genomics Inc. netted $417.1mm in its initial public offering of 11.5mm Class A common shares (including the overallotment) at $39. The company originally intended to sell 9mm shares between $31-35, later upped to a $36-38 range.
Deal Industry
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IPO nets $417mm for 10x Genomics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice